Monrovia's Starr Surgical Says It Is Working to Address FDA Concerns

Monrovia's Starr Surgical reports that it is responding to a U.S. Food and Drug Administration Warning Letter following an inspection of its Monrovia facilities. The company says it "is currently drafting a response to the FDA's observations" and "will continue to work diligently to address the observations identified in the Form 483 and 2014 Warning Letter." http://goo.gl/8VpJzO

- Brad Haugaard